Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE:MTEC) (Frankfurt :3CM) (OTCPK :CANVF), a leading digital cannabis educator and business technology company, is pleased to report the steady growth of its products and services line entering 2019 as it persists in assembling a wide-ranging partner network to promote cannabis education, drive audiences to its Cannvas.Me platform and create revenue-generating opportunities.
“We are continuing to amass a strong network of strategic partners across the cannabis and health sciences space to bolster Cannvas.Me content and user databases, contribute to Cannvas Data analytics and reinforce the brand’s mission within the sector,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. “We expect to leverage the relationships we’ve nurtured throughout the industry to drive revenue to all aspects of the business, from education and data analysis to creative work and content creation, and feel the Company will continue to make strides through 2019.”
Working toward its goal of becoming the household name for cannabis education, Cannvas has accomplished a great deal going into the new year, solidifying its reputation through the successful launch of the product and services side of the business, generating shareholder value and propelling company growth.
Cannvas executives are actively engaged in talks with leading cannabis companies across a range of sectors for inclusion in the Company’s 2019 media plan. Its partner network will have the opportunity to access ad space allocated across several platforms and user touchpoints to reach thousands of potential customers through geo-targeted promotions while also benefiting from Cannvas Data analytics surveying the industry landscape and returning relevant results and learnings. Cannvas also plans to work with industry leaders to publish and share insights gleaned from its Cannvas.Me platform about how Canadians are learning about cannabis and what areas of interest they have, to help shape public policy and drive corporate decision-making.
Partnership agreements with clinics, pharmacies, insurance agencies and other such organizations promises to generate steady additional income with the potential for ancillary services such as creative work and content creation to strengthen those streams. Physical locations of Cannvas Marché and Cannvas Kiosks offer more potential for revenue generation and new partnerships.
Cannvas partnered with a number of high-profile cannabis-related companies in 2018, operating in wide range of areas within the cannabis industry, including: Namaste Technologies Inc., AgraFlora Organics International Inc. (formerly PUF Ventures Inc.), The Wellness Soldier, MOOD, Business of Cannabis, and the Global Cannabis Partnership.
Cannvas has also benefited enormously from the support of Tech West Canada and expects to continue leveraging the access to markets and international technology events Tech West provides. Tech West Canada has built a proven record of enabling tech companies from Western Canada to effectively deploy international events as prime sales and business development vehicles.
“We have enjoyed early dividends due to our partnerships with leading companies like Namaste Technologies and organizations like Tech West,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “As the leading cannabis technology company in Canada, Namaste brought instant credibility to Cannvas.Me, further to driving future revenue. Tech West has been instrumental by supporting our efforts on the international stage at a number of prestigious conferences – The relationships developed at those conferences lead to important partnerships and we will continue to pursue partnerships with leading cannabis companies in Canada and around the world as we grow our offering to include other languages in support of our recently-announced international expansion program.”
Cannvas announced letters of intent in 2018 with Loop Media Group – GetintheLoop.com, CanvasRX, Natures Hemp, Marihuana Patient Relief, Advica Health and Blox Labs Inc. As part of its growing corporate social responsibility program, Cannvas has also entered into agreements with charitable organizations Pancreatic Cancer Canada and Sistema Toronto, with an eye on expanding that program in 2019.
Cannvas forms strategic partnerships with leading companies to disseminate its cannabis education in a number of ways, benefiting both parties. Cannvas offers a revenue-sharing model to drive users to Namaste’s services should they so choose; AgraFlora Organics and MOODTM will be part of the Cannvas Marché program promoting their own brands and products in locations across Canada; and The Wellness Soldier contributes to Cannvas Culinary content with expert advice and reliable recipes using cannabis to prepare healthy meals.
Cannvas will also be adding two additional independent oversight boards in 2019 to further strengthen its content and connect its brand to outside industries. Users can look forward to the creation of a Science and Wellness Advisory Board and a Culinary Advisory Board with leading experts from Canada and the United States on each board.
Cannvas.Me is an unbiased educational resource for medicinal and adult-use cannabis users offering innovative tools and physician-backed content to audiences wishing to learn about health care through cannabis.
- Cannvas Academy – educational learning modules created by licensed medical practitioners and certified educators with a focus on health care, lifestyle and wellness;
- Cannvas Strain Matcher – an interactive experience where users learn which strain is best for alleviating specific ailments;
- Cannvas Culinary – a culinary training module with recipes, ideas and more;
- Cannvas Health & Fitness – combining a cannabis-healthy lifestyle with training and fitness activities;
- Cannvas Cannabis & Science – for active and potential cannabis users interested in learning more about the science of the plant and how it impacts the human endocannabinoid system.
Additional relevant modules and tools will be added to the platform as they become available.The team at Cannvas is always working on new and exciting modules and tools which are added to the platform as they become available. New versions are first introduced in English and then a short time later will come out in German on its sister sites.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.
For additional information:
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) today announced that it has retained KCSA Strategic Communications (” KCSA “), a leading New York City -based communications firm.
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), today announced the closing of its previously announced marketed public offering of 5,000,000 subordinate voting shares in the United States and Canada (the “Offering”) at a public offering price of C$50.00 per share ( $39.63 per share after giving effect to the conversion rate published by Bloomberg at 4:30pm ET on April 7, 2021 to convert Canadian dollars to U.S. dollars). In connection with the closing of the Offering, the underwriters exercised in full their option to purchase an additional 750,000 subordinate voting shares. As a result, the gross proceeds from the Offering, before deducting underwriting discounts and commissions and offering expenses payable by Trulieve, were C$287.5 million (or $227.9 million after giving effect to the conversion rate denoted above).
The Offering was conducted through a syndicate of underwriters led by Canaccord Genuity, as sole book-running manager, and included Cormark Securities Inc., as co-lead manager, as well as ATB Capital Markets Inc., Echelon Wealth Partners Inc., Eight Capital and PI Financial Corp. All of the shares in the Offering were sold by Trulieve. Trulieve intends to use the net proceeds from the Offering primarily to fund Trulieve’s business development and for general working capital purposes.
Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or “ Ayurcann ”), is pleased to announce that the Company intends to complete a non-brokered private placement (the “Financing” ) of up to 2,645,503 units (the “Units” ) at a price of $0.189 per Unit. Each Unit will consist of one common share ( “Common Share” ) of the Company and one-half of a common share purchase warrant ( “Warrant” ), with each whole Warrant entitling the holder to acquire one additional Common Share at an exercise price of $0.38 per Common Share for a period of 36 months from the closing date ( “Closing Date” ) of the Financing, for gross proceeds of up to $500,000 .
The Company will have an option, prior to the closing date, to upsize the offering with the sale of an additional 25% of Units, accounting to aggregate proceeds of up to $625,000.
Lobe invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference
Nextleaf Solutions Receives Amendment to Standard Processing Licence to Allow for Direct to Province Sales
Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis processor, is pleased to announce that its wholly-owned subsidiary, Nextleaf Labs Ltd. (“Nextleaf Labs”), has received an amendment to its existing Standard Cannabis Processing Licence from Health Canada (the “Amendment” or the “Amended Licence”) that authorizes the sale of cannabis extracts, edibles, and topical products, directly to provincially-authorized distributors and retailers across Canada.